Irvine, CA, United States of America

Wei Guo

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Zymo Research Corporation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Guo. Retrieved from https://idiyas.com/inventor/wei-guo-a9b4lwx1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Detection: The Contributions of Wei Guo

Introduction

Wei Guo is an accomplished inventor based in Irvine, California. He has made significant contributions to the field of cancer research through his innovative patent. His work focuses on the detection of DNA methylation, which plays a crucial role in understanding various cancers.

Latest Patents

Wei Guo holds a patent for "Assays to determine DNA methylation and DNA methylation markers of cancer." This patent outlines methods for determining a genomic methylation profile in a DNA sample. The methods can be utilized to assess whether a subject has, or is at risk for developing, bladder cancer or other cancers of the urinary tract. Additionally, the patent provides methods for the treatment of such subjects.

Career Highlights

Wei Guo is currently employed at Zymo Research Corporation, where he continues to advance his research in molecular biology and cancer diagnostics. His work has the potential to significantly impact early detection and treatment strategies for cancer patients.

Collaborations

Wei Guo collaborates with notable colleagues, including Paolo Piatti and Xiaojing Yang. Their combined expertise enhances the research efforts at Zymo Research Corporation.

Conclusion

Wei Guo's innovative work in DNA methylation detection represents a significant advancement in cancer research. His contributions are paving the way for improved diagnostic methods and treatment options for patients at risk of urinary tract cancers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…